We are live on ! Find out more
PMD

Psychemedics Corporation
PMD

Delisted

PMD was delisted on the 12th of December, 2024.

Back to rankings

45 hedge funds and large institutions have $23.8M invested in Psychemedics Corporation in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 18 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less funds holding

Funds holding: 46 → 45 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

19% less capital invested

Capital invested by funds: $29.6M → $23.8M (-$5.74M)

44% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 18

Holders
45
Holders Change
-1
Holders Change %
-2.17%
% of All Funds
0.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
10
Reduced
18
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$264K
2
AA
Ancora Advisors
Ohio
+$169K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$142K
4
TCM
Tieton Capital Management
Washington
+$98.7K
5
MC
Moors & Cabot
Massachusetts
+$34K

Top Sellers

Rank Fund Capital Flow
1
DRZID
DePrince Race & Zollo Inc (DRZ)
Florida
-$1.29M
2
UIC
Uniplan Investment Counsel
Wisconsin
-$982K
3
KCM
Kennedy Capital Management
Missouri
-$425K
4
AL
AJO LP
Pennsylvania
-$370K
5
William Blair & Company
William Blair & Company
Illinois
-$80.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$101K – – –
Morgan Stanley
27
Morgan Stanley
New York
$59K -$4.88K -574 -8%
OSAM
28
O'Shaughnessy Asset Management
Connecticut
$36K -$10.6K -1,243 -24%
PCM
29
Prelude Capital Management
New York
$28K -$19.5K -2,297 -43%
UBS Group
30
UBS Group
Switzerland
$17K -$13K -1,525 -44%
HIM
31
Hillsdale Investment Management
Ontario, Canada
$11K – – –
JP Morgan Chase
32
JP Morgan Chase
New York
$9K -$45.4K -5,348 -85%
Victory Capital Management
33
Victory Capital Management
Texas
$8K +$7.49K +882 New
NFG
34
Next Financial Group
Texas
$4K -$850 -100 -20%
LFG
35
Larson Financial Group
Missouri
$4K – – –
APA
36
American Portfolios Advisors
New York
$3.1K +$943 +111 +48%
TRCT
37
Tower Research Capital (TRC)
New York
$2K -$10.8K -1,270 -82%
BCA
38
Bray Capital Advisors
Florida
$2K +$1.75K +206 New
DA
39
Denali Advisors
California
$1K -$714 -84 -46%
Fidelity Investments
40
Fidelity Investments
Massachusetts
$1K -$408 -48 -32%
AF
41
Advisornet Financial
Minnesota
$1K +$518 +61 New
Bank of America
42
Bank of America
North Carolina
$1K +$1.28K +151 New
UIC
43
Uniplan Investment Counsel
Wisconsin
– -$982K -97,375 Closed
AL
44
AJO LP
Pennsylvania
– -$370K -36,645 Closed
PAM
45
Panagora Asset Management
Massachusetts
– -$33K -3,241 Closed
PNC Financial Services Group
46
PNC Financial Services Group
Pennsylvania
– -$28K -2,832 Closed
Russell Investments Group
47
Russell Investments Group
United Kingdom
– -$19K -1,852 Closed
CCM
48
Copeland Capital Management
Pennsylvania
– -$8K -760 Closed
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
– -$2K -170 Closed
Barclays
50
Barclays
United Kingdom
– +$323 +38 New
1
2

PMD Hedge Fund Activity: Q3 2019 in Review

45 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q3 2019, worth a combined $23.8M — down 19% from $29.6M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of PMD and 6 opened new positions — a net loss of 1 holder — while 18 trimmed existing stakes and 10 added.

The largest buyer was Renaissance Technologies, adding an estimated $264K. The largest seller was DePrince Race & Zollo Inc (DRZ), cutting an estimated $1.29M.

  • 45 institutional investors held Psychemedics Corporation (PMD) as of Q3 2019, down from 46 in Q2 2019.
  • Funds reported $23.8M of Psychemedics Corporation stock for Q3 2019, down 19% quarter-over-quarter.
  • 6 funds opened new Psychemedics Corporation positions in Q3 2019 and 7 closed out, a net change of -1 holder.
  • The largest Psychemedics Corporation buyer in Q3 2019 was Renaissance Technologies, an estimated $264K added.
  • The largest Psychemedics Corporation seller in Q3 2019 was DePrince Race & Zollo Inc (DRZ), an estimated $1.29M sold.

Based on aggregated 13F filings for Q3 2019.